EC gives nod for Clinigen to update Cardioxane advice
Clinigen Group
925.00p
16:39 04/04/22
0.00%
0.00p
Global pharmaceutical and services company Clinigen Group announced on Thursday that its commercial medicines operation has received European Commission approval to update the current product information for Cardioxane.
Food & Drug Retailers
3,784.33
16:59 23/04/24
-0.20%
-7.50
FTSE AIM 100
3,646.83
17:14 23/04/24
n/a
n/a
FTSE AIM 50
3,997.69
17:14 23/04/24
n/a
n/a
FTSE AIM All-Share
754.87
17:14 23/04/24
n/a
n/a